Find Investors Actively Funding Biotech Startups
Skip weeks of manual investor research with a filtered list of active investors.
Sourced from recent funding rounds. Stages, sectors, offices, and portfolio links included.
One-time purchase · Instant access
Download Biotech Investor ListCSV + Excel · No subscription
Includes: firm name · website · stages · sectors · offices · portfolio links
New Era Capital Partners
Early-growth VC investing from Seed to Series B in technology companies
Newpath Partners
Boston-based life sciences venture firm that co-founds biotech companies with academic scientists from pre-company formation through growth.
Newtree Impact
Brussels-based impact holding investing in Agri-Food tech and food loss companies to fight climate change and reshape food systems
Nissay Capital
Corporate VC of Nippon Life Insurance since 1991, having backed over 1,000 Japanese startups with 250+ IPO exits across broad sectors.
No Label Ventures
London micro-VC backing immigrant founders as the first check, often pre-product; run solo by ex-KKR/Silver Lake investor Ramzi Rafih.
Norrsken Evolve
Stockholm pre-seed fund backing European impact-tech founders in climate, energy, health, and security with €250K initial checks plus sprints.
Norrsken Launcher
Early-stage deep tech impact fund investing €1–3M in science-driven startups with global impact potential, making 2–4 selective investments per year with deep operational involvement.
Northern Gritstone
UK investor backing deep tech and life sciences university spinouts from Leeds, Manchester, Sheffield, and Liverpool from early to growth stage.
Northern Light Venture Capital
Leading early-stage VC firm focused on enterprise tech and healthcare
Northpond Ventures
A science-driven venture capital firm building breakthrough businesses
Norwest
A global venture and growth equity investment firm managing over $15.5 billion in capital. They partner with visionary leaders to scale their businesses.
Novalis Biotech
Early-stage life sciences VC backing enabling technologies in genomics, diagnostics, bioinformatics, digital health, and research tools from pre-seed to Series A.
Novalis LifeSciences
Venture capital and private equity for breakthrough life science technologies
Novartis Venture Fund
Corporate VC investing in innovative life science companies
Nucleus Capital
First-check deep tech fund backed by the EIF investing up to €1M in technical founders building in programmable biology, food technology, and neo-industrial infrastructure across Europe and the US.
NVentures
Corporate venture capital arm of NVIDIA investing in tech visionaries across AI & computing
NY Ventures
New York State's venture arm deploying $300M+ via direct and fund-of-funds programs since 2015; 71% of portfolio women-, minority-, or veteran-led.
NYBC Ventures
Corporate VC arm of New York Blood Center Enterprises deploying a $50M fund into early-stage companies advancing hematology, transfusion medicine, cell therapy, and infectious disease.
Oak Grove Ventures
Singapore-based VC investing in early-stage Web3, AI, and biotechnology startups, evolved from a multi-continent family office.
Obvious Ventures
Venture capital for startups reimagining trillion-dollar industries through a world positive lens
Octopus Ventures
European venture capital firm backing founders solving tomorrow's challenges
Ohio Innovation Fund
Early-stage VC based in Dublin, Ohio investing $500K–$4M in disruptive founders across AI/ML, cybersecurity, medtech, AR/VR, SaaS, and biotech with a team track record of 7 unicorns.
Olive Tree Capital
Boston-based family office-rooted VC investing in technology, life sciences, fintech, and frontier startups globally across early and growth stages.
Omega Funds
Investing in the future of medicine through life sciences
OMX Ventures
Lincolnshire-based early-stage VC investing at the convergence of biology, big data, and AI, backing therapeutics, bio-tools, diagnostics, and synthetic biology companies across North America and Europe.
Ono Venture Investment
Corporate VC arm of Ono Pharma investing in early-stage oncology, immunology, and neurology startups synergistic with pharma R&D.
OrbiMed
Global leader investing in healthcare from early-stage to public companies
Oregon Venture Fund
Regional VC providing capital and support to Oregon/SW Washington startups and growth companies
OSF Ventures
Corporate arm of OSF HealthCare's hospital system, investing post-seed in health IT and medtech startups that partner directly with its clinicians.
Overlap Holdings
Frontier tech VC investing in Seed through Series B, pairing equity with free debt advisory and non-dilutive government funding support.
OVNI Capital
Paris- and San Francisco-based pre-seed and seed VC backing European deep tech founders building in hardware, biotech, quantum, cybersecurity, and AI.
Oxford Science Enterprises
Partnering with Oxford University to build science-based companies
Oyster Bay Venture Capital
Hamburg-based early-stage VC investing across the food value chain, from innovative food brands and ingredients to agtech and food robotics.
Pace Ventures
Backing the best teams building essential technology at the earliest stages
Page One Ventures
Silicon Valley seed firm investing at the convergence of deep tech, life sciences and B2B software, backed by long-term institutional capital.
Pamir Ventures
San Francisco pre-seed firm backing technical founders building AI-focused B2B companies across life sciences, biotech, climate, and enterprise.
Ready to download the full list?
667 active investors · CSV + Excel · One-time purchase · Updated July 2026
Download Biotech Investor ListIncludes: firm name · website · stages · sectors · offices · portfolio links